Des-gamma-carboxy prothrombin (DCP) ratio is a useful prognostic tumor marker for single nodule hepatocellular carcinoma (HCC)

Hepato-Gastroenterology

Volumn 55, Issue 81, 2008, Pages 197-201

  Murakami, Naohiko ^a   Tamano, Masaya ^a   Yoneda, Masashi ^a   Sugaya, Hitoshi ^a   Hiraishi, Hideyuki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Des gamma carboxy prothrombin; Hepatocellular carcinoma; Prognosis

Indexed keywords

DECARBOXYPROTHROMBIN; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE; TUMOR THROMBUS;

AGED; ALPHA-FETOPROTEINS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 41549107119     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, Coleman MS, Furie B: Des-y-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984; 310:1427-1431.
2. Motohara K, Kuroki Y, Kan H, et al: Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin. Pediatr Res 1985; 19:345-357.
3. Watanabe K, Naraki T, Iwasaki Y, Endo F, Matsuda I: Purification of PIVKA-II from PLC/PRF/5 cell and production of a new monoclonal antibody. Acta Hepatol Jpn 1994; 35:192.
4. Sekiya C, Kohda H, Hasebe C, Namiki M, Watanabe K, Naraki T: Characteristics of the PIVKA-II found in hepatocellular carcinoma, investigation using monoclonal antibodies MU-3 and 19B7. Int Hepatol Commun 1994;2:277-284.
5. Sugimoto H, Takeda S, Inoue S, Kaneko T, Watanabe K, Nakao A: Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma. Liver International 2003; 23:38-44.
6. Nagaoka S, Yatsuhashi H, Hamada H, Yano K, Matsumoto T, Daikoku M, Arisawa K, Ishibashi H, Koga M, Sata M, Yano M: The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. Cancer 2003; 98:2671-2677.
7. Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. 4th Edition. Tokyo: Kinbara Shuppan Co. Ltd., 2003.
8. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
9. Okuda H, Nakanishi T, Takatsu K, Saitou A, Hayashi N, Watanabe K, Magario N, Yokoo T, Nariki T: Measurement of serum levels of des-gammma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit increased sensitivity. Cancer 1999; 85:812-818.
10. Nakao A, Taniguchi K, Inoue S, Takeda S, Harada A, Nonami T, Watanabe K, Takagi H: Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies. Am J Gastroenterol 1997; 92:1031-1034.
11. Nakao A, Taniguchi K, Inoue S, Harada A, Nonami T, Watanabe K, Takagi H: Usefulness of simultaneous determination of α-fetoprotein and des-y-carboxy prothrombin in hepatocellular carcinoma. Sem Surg Oncol 1996;12:160-163.
12. Sassa T, Kumada T, Nakano S, Uematsu T: Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1999; 11:1387-1392.
13. Kasahara A, Hayashi N, Fusamoto H, Kawada Y, Imai Y, Yamamoto H, Hayashi E, Ogihara T, Kamada T: Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes. Dig Dis Sci 1993; 38:2170-176.
14. Izuno K, Fujiyama S, Yamasaki K, Sato T: Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study. Hepatogastroenterology 1995; 42:387-393.
15. Kuromatsu R, Tanaka M, Shimauchi Y, Shimada M, Tanikawa K, Watanabe K, and Yokoo T: Usefulness of ED036 kit for measuring PIVKA-II levels in small hepatocellular carcinoma. J Gastroenterol 1997; 32:507-512.
16. Tanaka Y, Kashiwagi T, Tsutsumi H, Nagasawa M, Toyama T, Ozaki S, Naito M, Ishibashi K, Azuma M: Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma. Hepatogastroenterology 1999; 46:2464-468.
17. Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Yoshida H, Shiina S, Omata M: Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 2001; 91:561-569.
18. Khan KN, Yatsuhashi H, Yamasaki K, Yamasaki M, Inoue O, Koga M, Yano M: Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000; 32:269-278.
19. Tamano M, Sugaya H, Oguma M, Murohisa T, Tomita Y, Matsumura A, Kojima K, Terano A: Immunolocalisation of PIVKA-II in paraffin-embedded specimens of hepatocellular carcinoma. Liver 1999; 19:406-410.
20. Tamano M, Sugaya H, Oguma M, Iijima M, Yoneda M, Murohisa T, Kojima K, Kuniyoshi T, Majima Y, Hashimoto T, Terano A: Serum and tissue PIVKA-II expression reflect the biological malignant potential of small hepatocellular carcinoma. Hepatol Res 2002; 22:261-269.
21. Ajisaka H, Shimizu K, Miwa K: Immunohistochemical study of protein induced by vitamin K absence or antagonist II in hepatocellular carcinoma. J Surg Oncol 2003; 84:89-93.
22. Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, Koike K, Takaki A, Shiratori Y: Desgamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 2005; 25:6409-6415.
23. Tang W, Miki K, Kokudo N, Sugawara Y, Imamura H, Minagawa M, Yuan LW, Ohnishi S, Makuuchi M: Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma. Int J Oncol 2003; 22:969-975.
24. Yuan LW, Tang W, Kokudo N, Sugawara Y, Karako H, Hasegawa K, Aoki T, Kyoden Y, Deli G, Li YG, Makuuchi M: Measurement of des-gamma-carboxy prothrombin levels in cancer and non-cancer tissue in patients with hepatocellular carcinoma. Oncol Rep 2004; 12:269-273.